Nicole Mabardi SN and Shaina Joseph SN University of South Florida College of Nursing January 30 2014 WHAT IS FIFTH DISEASE Also known as Erythema Infectiousum Mild rash due to parvovirus B19 ID: 504192
Download Presentation The PPT/PDF document "FIFTH DISEASE" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
FIFTH DISEASE
Nicole Mabardi, SN and Shaina Joseph, SN
University of South Florida, College of Nursing
January 30, 2014Slide2
WHAT IS FIFTH DISEASE?
Also known as
Erythema
Infectiousum
Mild rash due to
parvovirus B19
Parovirus
B19 only affects humans
Parovirus
B19 c
an
cause different symptoms depending on age; however, those affected usually do not have any symptoms.
It can cause the body to temporarily stop making new red blood cell
T
his can lead to anemia.
Fifth disease is mostly seen in children 2 to 15 years of age, but it can be found in adults as well.
Quick Fact
Fifth disease got its name because it was fifth in a list of historical classifications of common skin rash illnesses in children.Slide3
SYMPTOMS
Symptoms
at first are usually mild and nonspecific.
They include:
LOW GRADE FEVER
RUNNY NOSE
HEADACHE
JOINT PAIN (in adults)
After several days,
an
erythematous
rash
appears on the
face-specifically the cheeks-
of the infected child, giving them a “slapped cheek” presentation.
Days later, the rash spreads and
erythematous
blotches appear on
their chest, back, arms/legs,
and
buttocks.
The rash varies in intensity and comes and goes for several weeks.
The rash may be itchy (especially
if the rash is on
the soles of the feet).
It usually
goes away in 7-10 days but can last for several weeks. Slide4Slide5
TRANSMISSION
The
virus spreads through respiratory secretions like saliva, mucous, and sputum.
Once infected by the virus, an individual will usually get sick within 4-14 days
.
The individual is most contagious when they have the fever like symptoms (right before the rash appears).
The virus can also spread through blood or blood products.
P
regnant women can also pass the virus to their baby.
Once a person has had Fifth Disease, they will have developed immunity to it (they won’t get it again).Slide6
Clinical Case
Five year old, Caucasian, male
Cultural considerations- Both parents present with child; sibling at home with grandma.
Admitted for Fifth Disease
Medical history of only a circumcision done at birth.
No known allergies
Subjective findings:
Mother states that patient had a fever of 101 a few days ago.
Patient states rashes itch.
Objective findings:
Rash over cheeks and body
Patient is itching
BP: 90/55; heart rate: 88; respirations:22; temperature: 98.7 F;
02 sat 97% Slide7
What
assessment data about this patient is particularly pertinent?
-
Fever/ flu-like symptoms that
have
lasted a few
days
.
-
R
ash that appears
first on
the child’s cheeks
and then spreads throughout the body after a few days of having these flu-like
symptoms. Slide8
Is
there additional data that you would like to obtain before you notify the physician about this patient?
-
When exactly symptoms appeared,
if anything was consumed
to relieve symptoms,
and the medical
history of
the patient
especially those with sickle cell
disease
(high
risk
). Slide9
Role Play With T
he Doctor
Nurse: Good morning doctor, I have a five year old Caucasian male who came in today with rashes over his cheeks and body. His parents say he did have a fever and other flu-like symptoms a few days ago. His parents are very concerned.
Doctor: Ok, I will come by and perform a physical exam. In the meantime, have blood work drawn to check for antibodies to the
parovirus
B19 virus. If
IgM
antibodies are seen, then the child may be in the middle of an infection or have had a recent infection of the
parovirus
B19
virus (depending on the stage they are at).
Nurse: Sounds good, Doc. I will get a blood sample of the patient.Slide10
What interventions would be appropriate for this patient? Which of these interventions are highest priority?
-
Treatment is symptomatic:
pain relief
fluids
rest
good hand washing**Slide11
What
potential problems or complications do you need to be prepared to handle?
How
would you do that?
Are
there other people that need to be involved to help? Consultations?
This is usually just a mild rash that tends to go away within a couple weeks or so, however, if the patient is a high risk
candidate (anemia) they should be closely monitored via blood test because it can lead to transient aplastic crisis, which is a rapid worsening of existing anemia lasting
7-10 days
. These patients will become very sick (fever, lethargy, rapid
HR,
and rapid breathing
).
If iron
levels are low,
iron supplements can be used
.
Parents
should be involved to make sure treatment is followed.
The Primary
Doctor should also be involved to confirm viral illness is resolving. Slide12
How often should the nurse reassess the patient?
Monitor Q2h (if hospitalized)
Educate parents and make sure they understand the disease processSlide13
Appropriate Patient/Family Teaching
Handwashing
is key
T
each
parents that
this
is a mild illness that will
resolve
O
nce
the rashes
appear,
child is able to return to school because it will not be contagious anymore
(it’s most
contagious during fever
).Slide14
Problems
Acute Pain
Knowledge Deficit
Fatigue
Body image disturbance
Priority Nursing Diagnosis:
Acute pain related to rashes as evidenced by verbal statements of discomfort from patient. Slide15
Goals
Short term goals
Patient will rate pain 0/10 by the end of my shift.
Patient will stop itching by the end of my shift.
Long term goals
Patient will not be in pain through discharge.Slide16
Developmental Stage and Milestones
Preschool (3-5 years of age)
Initiative vs Guilt
Children need to begin asserting control and power over the environment. Success in this stage leads to a sense of purpose. Children who try to exert too much power experience disapproval, resulting in a sense of guilt.
Milestones
Hops, skips, jumps, balances on one foot
Vocabulary of 2,100 words; uses sentences
Expresses through play and story-telling; imagination
Gender aware
Mood swings& dramatic behaviorSlide17
Family Structure/Support System
Both
p
arents at the bedside of
child
Open to healthcare advice
Sibling
at home with grandma
Approach to Invasive Procedures
Standard
Precautions
Good Hygiene/
Handwashing
GlovesSlide18
Treatment
Treatment
is
symptomatic:
pain relief
fluids
rest
good hand washing
Child can go to school once rash is present. Slide19
Documentation
Temperature
F
lu-like symptoms
Location
of
rashes
OLDCART
Patient/family
education. Slide20
Epidemiological and clinical features of erythema infectiosum in children in Novi Sad from 2000 to
2009
The reason for this study was to analyze the epidemiological (population)
and clinical characteristics of erythema
infectiosum (EI)
in
children. There were 88 children observed in the study that lasted from January
2000-December
2009
in
Vojvodina, in Novi
Sad(Serbia). The clinical characteristics were compared during and after the outbreak of EI and the results detected that 88 (44 boys, 44 girls) out of the 41,345 children had EI.
T
he average age of children getting infected were
7.59 +/-
3.339. The most common signs were rashes on the cheeks and limbs, though no children had serious complications. Slide21
Infectious diseases in children Fifth disease (Slapped cheek disease)
This article describes
Fifth
D
isease
, explains why it is important and analyzes the characteristics of the viral outbreak it can resemble. Slide22
References
Lowth
, M. (2013). Infectious diseases in children Fifth
disease
(Slapped cheek disease).
Practice Nurse
,
43
(10), 32-35
.
Prćić
, S.,
Gajinov
, Z.,
Zrnić
, B.,
Radulović
, A.,
Matić
, M., &
Djuran
, V. (2013). Epidemiological and clinical features of erythema infectiosum in children in Novi Sad from 2000 to 2009.
Vojnosanitetski
Pregled
: Military Medical & Pharmaceutical Journal Of Serbia & Montenegro
,
70
(12), 1081-1084.
doi:10.2298/VSP110607026P